Geode Capital Management
YMAB

Geode Capital Management’s Y-mAbs Therapeutics YMAB Stock Holding History

Geode Capital Management’s Portfolio YMAB Stock Details YMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-848,461
Closed -$3.83M – 4577
2025
Q2 		$3.83M Sell
848,461
-1,039
-0.1% -$4.67K ﹤0.01% 2870
2025
Q1 		$3.76M Buy
849,500
+27,191
+3% +$158K ﹤0.01% 2793
2024
Q4 		$6.44M Buy
822,309
+8,820
+1% +$107K ﹤0.01% 2621
2024
Q3 		$10.7M Buy
813,489
+47,846
+6% +$607K ﹤0.01% 2338
2024
Q2 		$9.25M Buy
765,643
+22,894
+3% +$309K ﹤0.01% 2367
2024
Q1 		$12.1M Buy
742,749
+4,201
+0.6% +$56.6K ﹤0.01% 2207
2023
Q4 		$5.04M Buy
738,548
+27,715
+4% +$160K ﹤0.01% 2702
2023
Q3 		$3.87M Sell
710,833
-831
-0.1% -$4.84K ﹤0.01% 2770
2023
Q2 		$4.83M Buy
711,664
+49,019
+7% +$367K ﹤0.01% 2696
2023
Q1 		$3.32M Buy
662,645
+31,351
+5% +$128K ﹤0.01% 2812
2022
Q4 		$3.08M Sell
631,294
-1,601
-0.3% -$11.6K ﹤0.01% 2890
2022
Q3 		$9.13M Buy
632,895
+6,727
+1% +$111K ﹤0.01% 2318
2022
Q2 		$9.47M Buy
626,168
+42,639
+7% +$497K ﹤0.01% 2287
2022
Q1 		$6.93M Sell
583,529
-37,448
-6% -$385K ﹤0.01% 2599
2021
Q4 		$10.1M Buy
620,977
+43,866
+8% +$938K ﹤0.01% 2448
2021
Q3 		$16.5M Buy
577,111
+26,064
+5% +$821K ﹤0.01% 2093
2021
Q2 		$18.6M Buy
551,047
+76,929
+16% +$2.47M ﹤0.01% 2015
2021
Q1 		$14.3M Buy
474,118
+43,240
+10% +$1.77M ﹤0.01% 2097
2020
Q4 		$21.3M Buy
430,878
+29,701
+7% +$1.37M ﹤0.01% 1680
2020
Q3 		$15.4M Buy
401,177
+42,614
+12% +$1.7M ﹤0.01% 1707
2020
Q2 		$15.5M Buy
358,563
+51,241
+17% +$1.94M ﹤0.01% 1670
2020
Q1 		$8.02M Buy
307,322
+35,104
+13% +$1.02M ﹤0.01% 1874
2019
Q4 		$8.51M Buy
272,218
+68,016
+33% +$2.01M ﹤0.01% 2126
2019
Q3 		$5.32M Buy
204,202
+39,223
+24% +$1M ﹤0.01% 2348
2019
Q2 		$3.77M Buy
164,979
+75,509
+84% +$1.73M ﹤0.01% 2575
2019
Q1 		$2.35M Buy
89,470
+11,438
+15% +$251K ﹤0.01% 2765
2018
Q4 		$1.59M Buy
+78,032
New +$1.79M ﹤0.01% 2894

Other funds holding YMAB

BIG
Brooklyn Investment Group Brooklyn, New York $3.2B AUM 26.32% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Geode Capital Management's YMAB Position: Q3 2025 in Review

Geode Capital Management sold out of Y-mAbs Therapeutics (YMAB) in Q3 2025, closing a stake of 848,461 shares — an estimated $3.83M sold.

Geode Capital Management first reported a position in YMAB in Q4 2018 and held it in 27 quarters. The position peaked at $21.3M in Q4 2020. 2 funds tracked by Wall St. Rank hold YMAB as of Q3 2025.

  • Geode Capital Management reported no remaining Y-mAbs Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Geode Capital Management sold 848,461 Y-mAbs Therapeutics shares in Q3 2025, an estimated $3.83M.
  • Geode Capital Management first reported a position in Y-mAbs Therapeutics in Q4 2018 and held it in 27 quarters.
  • Geode Capital Management's Y-mAbs Therapeutics position peaked at $21.3M in Q4 2020.
  • 2 funds tracked by Wall St. Rank held Y-mAbs Therapeutics as of Q3 2025.

Based on Geode Capital Management's 13F filing for Q3 2025, filed 12 Nov 2025.